Trials / Conditions / Relapsed CLL
Relapsed CLL
4 registered clinical trials studyying Relapsed CLL — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukem NCT06916767 | Paolo Caimi, MD | Phase 1 |
| Withdrawn | Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL NCT03639324 | Virginia Commonwealth University | Phase 1 |
| Active Not Recruiting | CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) NCT03774654 | Baylor College of Medicine | Phase 1 |
| Unknown | Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Follow NCT03091933 | Ciusss de L'Est de l'Île de Montréal | Phase 1 / Phase 2 |